SSY Group (HK:2005) has released an update.
SSY Group Limited has announced the successful registration of their product, Phenylephrine Hydrochloride, as a bulk drug in China, a key development in the treatment of low blood pressure during anesthesia. This update aims to keep shareholders and potential investors in the loop regarding the latest business progression within the Group.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.
